Literature DB >> 26643349

Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa.

Krystyna M Kazmierczak1, Sharon Rabine2, Meredith Hackel2, Robert E McLaughlin3, Douglas J Biedenbach2, Samuel K Bouchillon2, Daniel F Sahm2, Patricia A Bradford3.   

Abstract

Metallo-β-lactamases (MBLs) hydrolyze all classes of β-lactams except monobactams and are not inhibited by classic serine β-lactamase inhibitors. Gram-negative pathogens isolated from patient infections were collected from 202 medical centers in 40 countries as part of a global surveillance study from 2012 to 2014. Carbapenem-nonsusceptible Enterobacteriaceae and Pseudomonas aeruginosa were characterized for bla genes encoding VIM, IMP, NDM, SPM, and GIM variants using PCR and sequencing. A total of 471 MBL-positive isolates included the following species (numbers of isolates are in parentheses): P. aeruginosa (308), Klebsiella spp. (85), Enterobacter spp. (39), Proteeae (16), Citrobacter freundii (12), Escherichia coli (6), and Serratia marcescens (5) and were submitted by sites from 34 countries. Of these, 69.6% were collected in 9 countries (numbers of isolates are in parentheses): Russia (72), Greece (61), Philippines (54), Venezuela (29), and Kuwait, Nigeria, Romania, South Africa, and Thailand (20 to 25 isolates each). Thirty-two different MBL variants were detected (14 VIM, 14 IMP, and 4 NDM enzymes). Seven novel MBL variants were encountered in the study, each differing from a previously reported variant by one amino acid substitution: VIM-42 (VIM-1 [V223I]), VIM-43 (VIM-4 [A24V]), VIM-44 (VIM-2 [K257N]), VIM-45 (VIM-2 [T35I]), IMP-48 (IMP-14 [I69T]), IMP-49 (IMP-18 [V49F]), and NDM-16 (NDM-1 [R264H]). The in vitro activities of all tested antibiotics against MBL-positive Enterobacteriaceae were significantly reduced with the exception of that of aztreonam-avibactam (MIC90, 0.5 to 1 μg/ml), whereas colistin was the most effective agent against MBL-positive P. aeruginosa isolates (>97% susceptible). Although the global percentage of isolates encoding MBLs remains relatively low, their detection in 12 species, 34 countries, and all regions participating in this surveillance study is concerning.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26643349      PMCID: PMC4750703          DOI: 10.1128/AAC.02379-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  51 in total

1.  Emergence of NDM-1 in association with OXA-48 in Klebsiella pneumoniae from Tunisia.

Authors:  Adam Ben Nasr; Dominique Decré; Fabrice Compain; Nathalie Genel; Farouk Barguellil; Guillaume Arlet
Journal:  Antimicrob Agents Chemother       Date:  2013-06-10       Impact factor: 5.191

2.  Avibactam and class C β-lactamases: mechanism of inhibition, conservation of the binding pocket, and implications for resistance.

Authors:  S D Lahiri; M R Johnstone; P L Ross; R E McLaughlin; N B Olivier; R A Alm
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

Review 3.  IMP-type metallo-β-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons.

Authors:  Wei-Hua Zhao; Zhi-Qing Hu
Journal:  Crit Rev Microbiol       Date:  2011-03-29       Impact factor: 7.624

4.  First report of a Pseudomonas aeruginosa isolate coharboring KPC and VIM carbapenemases.

Authors:  A Correa; M C Montealegre; M F Mojica; J J Maya; L J Rojas; E P De La Cadena; S J Ruiz; M Recalde; F Rosso; J P Quinn; M V Villegas
Journal:  Antimicrob Agents Chemother       Date:  2012-07-23       Impact factor: 5.191

5.  Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases.

Authors:  S Mushtaq; S Irfan; J B Sarma; M Doumith; R Pike; J Pitout; D M Livermore; N Woodford
Journal:  J Antimicrob Chemother       Date:  2011-06-13       Impact factor: 5.790

Review 6.  OXA-48-like carbapenemases: the phantom menace.

Authors:  Laurent Poirel; Anaïs Potron; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2012-04-11       Impact factor: 5.790

Review 7.  The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide.

Authors:  P Nordmann; L Poirel
Journal:  Clin Microbiol Infect       Date:  2014-09       Impact factor: 8.067

8.  VIM-4 carbapenemase-producing Enterobacter cloacae in the United Arab Emirates.

Authors:  Á Sonnevend; A Ghazawi; N Yahfoufi; A Al-Baloushi; R Hashmey; M Mathew; W Z Tariq; T Pál
Journal:  Clin Microbiol Infect       Date:  2012-10-19       Impact factor: 8.067

9.  Genotypic and phenotypic profiles of Escherichia coli isolates belonging to clinical sequence type 131 (ST131), clinical non-ST131, and fecal non-ST131 lineages from India.

Authors:  Arif Hussain; Amit Ranjan; Nishant Nandanwar; Anshu Babbar; Savita Jadhav; Niyaz Ahmed
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.191

Review 10.  Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa.

Authors:  Duck Jin Hong; Il Kwon Bae; In-Ho Jang; Seok Hoon Jeong; Hyun-Kyung Kang; Kyungwon Lee
Journal:  Infect Chemother       Date:  2015-06-30
View more
  67 in total

1.  Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam-β-Lactamase Inhibitor Combinations.

Authors:  Gina K Thomson; James W Snyder; Christi L McElheny; Kenneth S Thomson; Yohei Doi
Journal:  J Clin Microbiol       Date:  2015-12-30       Impact factor: 5.948

2.  In Vitro Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015.

Authors:  James A Karlowsky; Krystyna M Kazmierczak; Boudewijn L M de Jonge; Meredith A Hackel; Daniel F Sahm; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

3.  Long-Term Compassionate Use of Cefiderocol To Treat Chronic Osteomyelitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae in a Pediatric Patient.

Authors:  Zain I Alamarat; Jessica Babic; Truc T Tran; Susan H Wootton; An Q Dinh; William R Miller; Blake Hanson; Audrey Wanger; Joshua L Gary; Cesar A Arias; Norma Pérez
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

Review 4.  What we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles.

Authors:  Karen Bush; Malcolm G P Page
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-02-04       Impact factor: 2.745

5.  In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014).

Authors:  Boudewijn L M de Jonge; James A Karlowsky; Krystyna M Kazmierczak; Douglas J Biedenbach; Daniel F Sahm; Wright W Nichols
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

6.  Carbapenem-Nonsusceptible Pseudomonas aeruginosa Isolates from Intensive Care Units in the United States: a Potential Role for New β-Lactam Combination Agents.

Authors:  Tomefa E Asempa; David P Nicolau; Joseph L Kuti
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

7.  Coexistence of mcr-1 and blaNDM-1 in Escherichia coli from Venezuela.

Authors:  Jose F Delgado-Blas; Cristina M Ovejero; Lorena Abadia-Patiño; Bruno Gonzalez-Zorn
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 8.  The global epidemiology of carbapenemase-producing Enterobacteriaceae.

Authors:  David van Duin; Yohei Doi
Journal:  Virulence       Date:  2016-08-11       Impact factor: 5.882

Review 9.  Metallo-β-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline.

Authors:  Sara E Boyd; David M Livermore; David C Hooper; William W Hope
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

Review 10.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.